We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.44B
AUM Growth
+$635M
Cap. Flow
+$85.7M
Cap. Flow %
1.58%
Top 10 Hldgs %
15.63%
Holding
579
New
166
Increased
105
Reduced
70
Closed
180
Avg Time Held Equity + Options
0.9 quarters
Top 10 Avg Time Held Equity + Options
0.9 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
1 quarter
Top 10 Avg Time Held Equity only
0.9 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.22%
2 Real Estate 17.69%
3 Consumer Staples 12.49%
4 Industrials 7.66%
5 Financials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KBIO
526
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
– –
-15,625
Closed -$565K –
HR icon
527
DELISTED
Healthcare Realty Trust Incorporated
HR
– –
-92,912
Closed -$2.15M –

Similar funds

UBS O'Connor's Q4 2013 Portfolio in Review

As of Q4 2013, UBS O'Connor held 579 positions worth $5.44B, up 13% from $4.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS O'Connor's Q4 2013 filing shows 166 new, 105 increased, 70 reduced and 180 closed positions. Its largest new stake was American Airlines Group: 2,596,600 shares worth $65.6M. The largest sale was ONYX PHARMACEUTICALS INC, an estimated $60.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 30% a quarter earlier, followed by Real Estate and Consumer Staples.

  • UBS O'Connor's largest Q4 2013 buy was American Airlines Group: 2,596,600 shares worth $65.6M.
  • UBS O'Connor added most to Crown Castle in Q4 2013, an estimated $53.8M increase.
  • UBS O'Connor's biggest Q4 2013 reduction was Colgate-Palmolive, cutting an estimated $46.1M.
  • UBS O'Connor fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $60.5M.
  • UBS O'Connor's ten largest holdings make up 16% of its $5.44B portfolio in Q4 2013.
  • UBS O'Connor opened 166 new positions and closed 180 in Q4 2013.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $5.44B.

Based on UBS O'Connor's 13F filing for Q4 2013, filed 13 Feb 2014.